_id
690f349cccc777a4e85d1684
Ticker
BFRG
Name
Bullfrog AI Holdings, Inc. Common Stock
Exchange
NASDAQ
Address
325 Ellington Boulevard, Gaithersburg, MD, United States, 20878
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.bullfrogai.com
Description
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Last Close
0.7238
Volume
65251
Current Price
0.6875
Change
-0.0363
Last Updated
2026-01-20T16:28:08.508Z
Image
data:image/webp;base64,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
Ipo Date
2023-02-13T00:00:00.000Z
Market Cap
8251613
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
-
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-09-30
Revenue
83413
Cost Of Revenue
68043
Gross Profit
15370
Operating Expenses
1585053
Operating Income
-1569683
Interest Expense
1543
Pretax Income
-1551612
Net Income
-1551612
Eps
-0.1494841651191861
Dividends Per Share
-
Shares Outstanding
11400405
Income Tax Expense
-
EBITDA
-1549638
Operating Margin
-1881.8205795259732
Total Other Income Expense Net
18071
Cash
1990712
Short Term Investments
-
Receivables
58335
Inventories
-
Total Current Assets
2536065
Property Plant Equipment
2956
Total Assets
2702356
Payables
168212
Short Term Debt
55606
Long Term Debt
-
Total Liabilities
758701
Equity
1943655
Bs_currency_symbol
USD
Depreciation
431
Change In Working Capital
65779
Cash From Operations
-1107172
Capital Expenditures
2
Cash From Investing
-
Cash From Financing
624249
Net Change In Cash
-482923
Cf_currency_symbol
USD
PE
-
PB
3.6714824968937387
ROE
-79.82959938878041
ROA
-57.41700945397275
FCF
-1107174
Fcf Percent
-13.27339863090885
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
83413
Quarters > 0 > income Statement > cost Of Revenue
68043
Quarters > 0 > income Statement > gross Profit
15370
Quarters > 0 > income Statement > operating Expenses
1585053
Quarters > 0 > income Statement > operating Income
-1569683
Quarters > 0 > income Statement > interest Expense
1543
Quarters > 0 > income Statement > pretax Income
-1551612
Quarters > 0 > income Statement > net Income
-1551612
Quarters > 0 > income Statement > eps
-0.1494841651191861
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10379775
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1549638
Quarters > 0 > income Statement > operating Margin
-1881.8205795259732
Quarters > 0 > income Statement > total Other Income Expense Net
18071
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1990712
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
58335
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2536065
Quarters > 0 > balance Sheet > property Plant Equipment
2956
Quarters > 0 > balance Sheet > total Assets
2702356
Quarters > 0 > balance Sheet > payables
168212
Quarters > 0 > balance Sheet > short Term Debt
55606
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
758701
Quarters > 0 > balance Sheet > equity
1943655
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1551612
Quarters > 0 > cash Flow > depreciation
431
Quarters > 0 > cash Flow > change In Working Capital
65779
Quarters > 0 > cash Flow > cash From Operations
-1107172
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
624249
Quarters > 0 > cash Flow > net Change In Cash
-482923
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.1494841651191861
Quarters > 0 > ratios > PB
3.6714824968937387
Quarters > 0 > ratios > ROE
-79.82959938878041
Quarters > 0 > ratios > ROA
-57.41700945397275
Quarters > 0 > ratios > FCF
-1107174
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-13.27339863090885
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
33257
Quarters > 1 > income Statement > cost Of Revenue
26735
Quarters > 1 > income Statement > gross Profit
6522
Quarters > 1 > income Statement > operating Expenses
1476195
Quarters > 1 > income Statement > operating Income
-1469673
Quarters > 1 > income Statement > interest Expense
2449
Quarters > 1 > income Statement > pretax Income
-1448729
Quarters > 1 > income Statement > net Income
-1448729
Quarters > 1 > income Statement > eps
-0.1492557042004229
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9706356
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1445848
Quarters > 1 > income Statement > operating Margin
-4419.138827915927
Quarters > 1 > income Statement > total Other Income Expense Net
20944
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2473635
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2702472
Quarters > 1 > balance Sheet > property Plant Equipment
3387
Quarters > 1 > balance Sheet > total Assets
2869194
Quarters > 1 > balance Sheet > payables
181793
Quarters > 1 > balance Sheet > short Term Debt
110291
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
681084
Quarters > 1 > balance Sheet > equity
2188110
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1448729
Quarters > 1 > cash Flow > depreciation
432
Quarters > 1 > cash Flow > change In Working Capital
-161581
Quarters > 1 > cash Flow > cash From Operations
-1431973
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
208680
Quarters > 1 > cash Flow > net Change In Cash
-1223293
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.1492557042004229
Quarters > 1 > ratios > PB
3.0497185927581336
Quarters > 1 > ratios > ROE
-66.20914853458008
Quarters > 1 > ratios > ROA
-50.4925425049683
Quarters > 1 > ratios > FCF
-1431973
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-43.05779234446884
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
431
Quarters > 2 > income Statement > gross Profit
-431
Quarters > 2 > income Statement > operating Expenses
2056620
Quarters > 2 > income Statement > operating Income
-2056620
Quarters > 2 > income Statement > interest Expense
1015
Quarters > 2 > income Statement > pretax Income
-2017553
Quarters > 2 > income Statement > net Income
-2017553
Quarters > 2 > income Statement > eps
-0.20821384357095885
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9689812
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2016107
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
39067
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3801928
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4082054
Quarters > 2 > balance Sheet > property Plant Equipment
3818
Quarters > 2 > balance Sheet > total Assets
4085872
Quarters > 2 > balance Sheet > payables
210533
Quarters > 2 > balance Sheet > short Term Debt
164070
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
839397
Quarters > 2 > balance Sheet > equity
3246475
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2017553
Quarters > 2 > cash Flow > depreciation
431
Quarters > 2 > cash Flow > change In Working Capital
-81291
Quarters > 2 > cash Flow > cash From Operations
-1798125
Quarters > 2 > cash Flow > capital Expenditures
5
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
164070
Quarters > 2 > cash Flow > net Change In Cash
-1634055
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.20821384357095885
Quarters > 2 > ratios > PB
2.051993546846965
Quarters > 2 > ratios > ROE
-62.145958308627044
Quarters > 2 > ratios > ROA
-49.37876174290335
Quarters > 2 > ratios > FCF
-1798130
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1724
Quarters > 3 > income Statement > cost Of Revenue
862
Quarters > 3 > income Statement > gross Profit
862
Quarters > 3 > income Statement > operating Expenses
1768761
Quarters > 3 > income Statement > operating Income
-1768761
Quarters > 3 > income Statement > interest Expense
2008
Quarters > 3 > income Statement > pretax Income
-1714743
Quarters > 3 > income Statement > net Income
-1714743
Quarters > 3 > income Statement > eps
-0.20796477725089513
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8245353
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1712304
Quarters > 3 > income Statement > operating Margin
-102596.34570765661
Quarters > 3 > income Statement > total Other Income Expense Net
54018
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5435983
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5547580
Quarters > 3 > balance Sheet > property Plant Equipment
4250
Quarters > 3 > balance Sheet > total Assets
5551830
Quarters > 3 > balance Sheet > payables
435934
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
588090
Quarters > 3 > balance Sheet > equity
4963740
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1714743
Quarters > 3 > cash Flow > depreciation
431
Quarters > 3 > cash Flow > change In Working Capital
227998
Quarters > 3 > cash Flow > cash From Operations
-1272035
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2469030
Quarters > 3 > cash Flow > net Change In Cash
1196995
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.20796477725089513
Quarters > 3 > ratios > PB
1.1420179516856241
Quarters > 3 > ratios > ROE
-34.54538311837445
Quarters > 3 > ratios > ROA
-30.886086209412035
Quarters > 3 > ratios > FCF
-1272035
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-737.8393271461717
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1724
Annuals > 0 > income Statement > gross Profit
-1724
Annuals > 0 > income Statement > operating Expenses
7236383
Annuals > 0 > income Statement > operating Income
-7236383
Annuals > 0 > income Statement > interest Expense
18158
Annuals > 0 > income Statement > pretax Income
-6993647
Annuals > 0 > income Statement > net Income
-6993647
Annuals > 0 > income Statement > eps
-0.8481925516105859
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
8245353
Annuals > 0 > income Statement > income Tax Expense
-44985
Annuals > 0 > income Statement > EBITDA
-6973765
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
242736
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5435983
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5547580
Annuals > 0 > balance Sheet > property Plant Equipment
4250
Annuals > 0 > balance Sheet > total Assets
5551830
Annuals > 0 > balance Sheet > payables
435934
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
588090
Annuals > 0 > balance Sheet > equity
4963740
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6993647
Annuals > 0 > cash Flow > depreciation
1724
Annuals > 0 > cash Flow > change In Working Capital
438025
Annuals > 0 > cash Flow > cash From Operations
-5610249
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
8421502
Annuals > 0 > cash Flow > net Change In Cash
2811253
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.8481925516105859
Annuals > 0 > ratios > PB
1.1420179516856241
Annuals > 0 > ratios > ROE
-140.89470842550173
Annuals > 0 > ratios > ROA
-125.9701215635205
Annuals > 0 > ratios > FCF
-5610249
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
65000
Annuals > 1 > income Statement > cost Of Revenue
5200
Annuals > 1 > income Statement > gross Profit
59800
Annuals > 1 > income Statement > operating Expenses
5427324
Annuals > 1 > income Statement > operating Income
-5367524
Annuals > 1 > income Statement > interest Expense
79089
Annuals > 1 > income Statement > pretax Income
-5355869
Annuals > 1 > income Statement > net Income
-5355869
Annuals > 1 > income Statement > eps
-0.8852940889636532
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6049819
Annuals > 1 > income Statement > income Tax Expense
-5
Annuals > 1 > income Statement > EBITDA
-5275055
Annuals > 1 > income Statement > operating Margin
-8257.72923076923
Annuals > 1 > income Statement > total Other Income Expense Net
11655
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2624730
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2770612
Annuals > 1 > balance Sheet > property Plant Equipment
5974
Annuals > 1 > balance Sheet > total Assets
2776586
Annuals > 1 > balance Sheet > payables
103656
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
184350
Annuals > 1 > balance Sheet > equity
2592236
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5355869
Annuals > 1 > cash Flow > depreciation
1725
Annuals > 1 > cash Flow > change In Working Capital
-1441647
Annuals > 1 > cash Flow > cash From Operations
-6001299
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
8568359
Annuals > 1 > cash Flow > net Change In Cash
2567060
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.8852940889636532
Annuals > 1 > ratios > PB
1.6045030477549111
Annuals > 1 > ratios > ROE
-206.61193656750388
Annuals > 1 > ratios > ROA
-192.89404326032042
Annuals > 1 > ratios > FCF
-6001300
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-92.3276923076923
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
10000
Annuals > 2 > income Statement > cost Of Revenue
800
Annuals > 2 > income Statement > gross Profit
9200
Annuals > 2 > income Statement > operating Expenses
2465000
Annuals > 2 > income Statement > operating Income
-2455801
Annuals > 2 > income Statement > interest Expense
347145
Annuals > 2 > income Statement > pretax Income
-2802487
Annuals > 2 > income Statement > net Income
-2802487
Annuals > 2 > income Statement > eps
-0.46040892058948385
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6086952
Annuals > 2 > income Statement > income Tax Expense
347604
Annuals > 2 > income Statement > EBITDA
-2454297
Annuals > 2 > income Statement > operating Margin
-24558.01
Annuals > 2 > income Statement > total Other Income Expense Net
-346686
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
57670
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
72670
Annuals > 2 > balance Sheet > property Plant Equipment
7699
Annuals > 2 > balance Sheet > total Assets
80369
Annuals > 2 > balance Sheet > payables
543993
Annuals > 2 > balance Sheet > short Term Debt
1578740
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3137721
Annuals > 2 > balance Sheet > equity
-3057352
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2802487
Annuals > 2 > cash Flow > depreciation
1045
Annuals > 2 > cash Flow > change In Working Capital
1136922
Annuals > 2 > cash Flow > cash From Operations
-910890
Annuals > 2 > cash Flow > capital Expenditures
8744
Annuals > 2 > cash Flow > cash From Investing
-8744
Annuals > 2 > cash Flow > cash From Financing
967290
Annuals > 2 > cash Flow > net Change In Cash
47656
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.46040892058948385
Annuals > 2 > ratios > PB
-1.368759468978384
Annuals > 2 > ratios > ROE
91.66386467766878
Annuals > 2 > ratios > ROA
-3487.0248478891112
Annuals > 2 > ratios > FCF
-919634
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-91.9634
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
555362
Annuals > 3 > income Statement > operating Income
-555362
Annuals > 3 > income Statement > interest Expense
40395
Annuals > 3 > income Statement > pretax Income
-585840
Annuals > 3 > income Statement > net Income
-585840
Annuals > 3 > income Statement > eps
-0.1036808066800002
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5650419
Annuals > 3 > income Statement > income Tax Expense
-196163
Annuals > 3 > income Statement > EBITDA
-555362
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
9917
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10014
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
10014
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
10014
Annuals > 3 > balance Sheet > payables
68594
Annuals > 3 > balance Sheet > short Term Debt
586304
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1019121
Annuals > 3 > balance Sheet > equity
-1009107
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-585840
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
97197
Annuals > 3 > cash Flow > cash From Operations
-382405
Annuals > 3 > cash Flow > capital Expenditures
5
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
387400
Annuals > 3 > cash Flow > net Change In Cash
4995
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.1036808066800002
Annuals > 3 > ratios > PB
-3.849604712384316
Annuals > 3 > ratios > ROE
58.05529046969251
Annuals > 3 > ratios > ROA
-5850.209706411025
Annuals > 3 > ratios > FCF
-382410
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.1494841651191861
Valuation > metrics > PB
3.6714824968937387
Valuation > final Score
43.285175031062614
Valuation > verdict
22.4% Overvalued
Profitability > metrics > ROE
-79.82959938878041
Profitability > metrics > ROA
-61.18187033849685
Profitability > metrics > Net Margin
-18.60156090777217
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.39034756682641725
Risk > metrics > Interest Coverage
-1017.2929358392742
Risk > final Score
-4009
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.330925126665417
Liquidity > metrics > Quick Ratio
11.330925126665417
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
49.502814072418666
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-2340
Prev Risks > 1
-8045
Prev Risks > 2
-3463
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:28:47.951Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.15
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.1493
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.21
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-14
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.19
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.217
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.1984
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2577
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2128
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2056
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2445
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-04-25
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.11
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.11
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-07
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.14
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.14
Earnings History > 11 > surprise Percent
-
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhat is BFRG’s book value per share - Trade Performance Summary & Reliable Price Breakout Signals bollywoodhelpline.com
Read more →Why Las Vegas Sands Corp. stock appeals to analysts - Quarterly Earnings Summary & Verified Momentum Watchlists bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bullfrog AI Holdings, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.15
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.